Verition Fund Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Verition Fund Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-113,655	Closed	-$18.8M	–	2531
2021 Q2	$18.8M	Buy	+113,655	New	+$19M	0.17%	88
2020 Q1	–	Sell	-2,467	Closed	-$274K	–	1182
2019 Q4	$274K	Buy	+2,467	New	+$254K	0.01%	853
2018 Q3	–	Sell	-8,275	Closed	-$773K	–	1503
2018 Q2	$773K	Buy	+8,275	New	+$713K	0.05%	520

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Verition Fund Management's PRAH Position: Q3 2021 in Review

Verition Fund Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 113,655 shares — an estimated $18.8M sold.

Verition Fund Management first reported a position in PRAH in Q2 2018 and held it in 3 quarters. The position peaked at $18.8M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Verition Fund Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Verition Fund Management sold 113,655 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $18.8M.
Verition Fund Management first reported a position in PRA Health Sciences, Inc. in Q2 2018 and held it in 3 quarters.
Verition Fund Management's PRA Health Sciences, Inc. position peaked at $18.8M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Verition Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.